1. |
Lugaresi E, Cirignotta F. Hypnogenic paroxysmal dystonia: epileptic seizure or a new syndrome? Sleep, 1981, 4(2): 129-138.
|
2. |
Vignatelli L, Bisulli F, Giovannini G, et al. Prevalence of nocturnal frontal lobe epilepsy in the adult population of Bologna and Modena, Emilia-Romagna region, Italy. Sleep, 2015, 38(3): 479-485.
|
3. |
Tinuper P, Bisulli F, Cross JH, et al. Definition and diagnostic criteria of sleep-related hypermotor epilepsy. Neurology, 2016, 86(19): 1834-1842.
|
4. |
Provini F, Plazzi G, Tinuper P, et al. Nocturnal frontal lobe epilepsy. A clinical and polygraphic overview of 100 consecutive cases. Brain, 1999, 122(Pt6): 1017-1031.
|
5. |
Derry CP, Davey M, Johns M, et al. Distinguishing sleep disorders from seizures: diagnosing bumps in the night. Arch Neurol, 2006, 63: 705-709.
|
6. |
Manni R, Terzaghi M, Repetto A. The FLEP scale in diagnosing nocturnal frontal lobe epilepsy, NREM and REM parasomnias: data from a tertiary sleep and epilepsy unit. Epilepsia, 2008, 49(9): 1581-1585.
|
7. |
Licchetta L, Bisulli F, Vignatelli L, et al. Sleep-related hypermotor epilepsy: Long-term outcome in a large cohort. Neurology, 2017, 88(1): 70-77.
|
8. |
Scheffer IE, Bhatia KP, Lopes-Cendes I, et al. Autosomal dominant nocturnal frontal lobe epilepsy. A distinctive clinical disorder. Brain, 1995, 118(Pt1): 61-73.
|
9. |
Alanis-Guevara I, Peña E, Corona T, et al. Sleep disturbances, socioeconomic status, and seizure control as main predictors of quality of life in epilepsy. Epilepsy Behav, 2005, 7(3): 481-485.
|
10. |
Tinuper P, Bisulli F. From nocturnal frontal lobe epilepsy to Sleep-Related Hypermotor Epilepsy: A 35-year diagnostic challenge. Seizure, 2017, 44: 87-92.
|
11. |
Freidel M, Krause E, Kuhn K, Peper R, Vogel H. Oxcarbazepin in der Epilepsietherapie [Oxcarbazepine in the treatment of epilepsy]. Fortschr Neurol Psychiatr, 2007, 75(2): 100-106.
|
12. |
Maiti R, Mishra BR, Sanyal S, et al. Effect of carbamazepine and oxcarbazepine on serum neuron-specific enolase in focal seizures: A randomized controlled trial. Epilepsy Res, 2017, 138: 5-10.
|
13. |
Nobili L, Francione S, Mai R, et al. Surgical treatment of drug-resistant nocturnal frontal lobe epilepsy. Brain, 2007, 130(Pt2): 561-573.
|
14. |
Mertens A, Raedt R, Gadeyne S, et al. Recent advances in devices for vagus nerve stimulation. Expert Rev Med Devices, 2018, 15(8): 527-539.
|
15. |
Möddel G, Coenen VA, Elger CE. Invasive Neurostimulation in der Epilepsietherapie [Invasive neurostimulation as adjunct treatment for epilepsy]. Nervenarzt, 2012, 83(8): 1001-1005.
|
16. |
Marini C, Guerrini R. The role of the nicotinic acetylcholine receptors in sleep-related epilepsy. Biochem Pharmacol, 2007, 74(8): 1308-1314.
|
17. |
De Fusco M, Becchetti A, Patrignani A, et al. The nicotinic receptor beta 2 subunit is mutant in nocturnal frontal lobe epilepsy. Nat Genet, 2000, 26(3): 275-276.
|
18. |
Kuryatov A, Gerzanich V, Nelson M, et al. Mutation causing autosomal dominant nocturnal frontal lobe epilepsy alters Ca2+ permeability, conductance, and gating of human alpha4beta2 nicotinic acetylcholine receptors. J Neurosci, 1997, 17(23): 9035-9047.
|
19. |
Phillips HA, Scheffer IE, Crossland KM, et al. Autosomal dominant nocturnal frontal-lobe epilepsy: genetic heterogeneity and evidence for a second locus at 15q24. Am J Hum Genet, 1998, 63(4): 1108-1116.
|
20. |
Phillips HA, Favre I, Kirkpatrick M, et al. CHRNB2 is the second acetylcholine receptor subunit associated with autosomal dominant nocturnal frontal lobe epilepsy. Am J Hum Genet, 2001, 68(1): 225-231.
|
21. |
Bar-Peled L, Chantranupong L, Cherniack AD, et al. A Tumor suppressor complex with GAP activity for the Rag GTPases that signal amino acid sufficiency to mTORC1. Science, 2013, 340(6136): 1100-1106.
|
22. |
Weckhuysen S, Marsan E, Lambrecq V, et al. Involvement of GATOR complex genes in familial focal epilepsies and focal cortical dysplasia. Epilepsia, 2016, 57(6): 994-1003.
|
23. |
Bonaglia MC, Giorda R, Epifanio R, et al. Partial deletion of DEPDC5 in a child with focal epilepsy. Epilepsia Open, 2016, 1(3-4): 140-144.
|
24. |
Ishida S, Picard F, Rudolf G, et al. Mutations of DEPDC5 cause autosomal dominant focal epilepsies. Nat Genet, 2013, 45(5): 552-555.
|
25. |
Dibbens LM, de Vries B, Donatello S, et al. Mutations in DEPDC5 cause familial focal epilepsy with variable foci. Nat Genet, 2013, 45(5): 546-551.
|
26. |
Picard F, Makrythanasis P, Navarro V, et al. DEPDC5 mutations in families presenting as autosomal dominant nocturnal frontal lobe epilepsy. Neurology, 2014, 82(23): 2101-2106.
|
27. |
Scheffer IE, Heron SE, Regan BM, et al. Mutations in mammalian target of rapamycin regulator DEPDC5 cause focal epilepsy with brain malformations. Ann Neurol, 2014, 75(5): 782-787.
|
28. |
Singh NA, Charlier C, Stauffer D, et al. A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. Nat Genet, 1998, 18(1): 25-29.
|
29. |
Heron SE, Cox K, Grinton BE, et al. Deletions or duplications in KCNQ2 can cause benign familial neonatal seizures. J Med Genet, 2007, 44(12): 791-796.
|
30. |
Singh NA, Westenskow P, Charlier C, et al. KCNQ2 and KCNQ3 potassium channel genes in benign familial neonatal convulsions: expansion of the functional and mutation spectrum. Brain, 2003, 126(Pt12): 2726-2737.
|
31. |
Dedek K, Kunath B, Kananura C, et al. Myokymia and neonatal epilepsy caused by a mutation in the voltage sensor of the KCNQ2 K+ channel. Proc Natl Acad Sci U S A, 2001, 98(21): 12272-12277.
|
32. |
Zhou X, Ma A, Liu X, et al. Infantile seizures and other epileptic phenotypes in a Chinese family with a missense mutation of KCNQ2. Eur J Pediatr, 2006, 165(10): 691-695.
|
33. |
Pisano T, Numis AL, Heavin SB, et al. Early and effective treatment of KCNQ2 encephalopathy. Epilepsia, 2015, 56(5): 685-691.
|
34. |
Kurahashi H, Wang JW, Ishii A, et al. Deletions involving both KCNQ2 and CHRNA4 present with benign familial neonatal seizures. Neurology, 2009, 73(15): 1214-1217.
|
35. |
Pascual FT, Wierenga KJ, Ng YT. Contiguous deletion of KCNQ2 and CHRNA4 may cause a different disorder from benign familial neonatal seizures. Epilepsy Behav Case Rep, 2013, 1: 35-38.
|
36. |
Cockcroft K, Alloway T, Copello E, Milligan R. A cross-cultural comparison between South African and British students on the Wechsler Adult Intelligence Scales Third Edition (WAIS-III). Front Psychol, 2015, 6: 297.
|
37. |
Dumont, R. and J. O. Willis, Wechsler Adult Intelligence Scale-Third Edition. 2008.
|
38. |
Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res, 1988, 16(3): 1215.
|
39. |
Kumar S, Stecher G, Li M, Knyaz C, Tamura K. MEGA X: Molecular Evolutionary Genetics Analysis across Computing Platforms. Mol Biol Evol, 2018, 35(6): 1547-1549.
|
40. |
Shahzad MA, Khaliq S, Amar A, Mahmood S. Metachromatic Leukodystrophy (MLD): a Pakistani Family with Novel ARSA Gene Mutation. J Mol Neurosci, 2017, 63(1): 84-90.
|
41. |
Menghi V, Bisulli F, Tinuper P, Nobili L. Sleep-related hypermotor epilepsy: prevalence, impact and management strategies. Nat Sci Sleep, 2018, 10: 317-326.
|
42. |
Yeh SB, Schenck CH. Sporadic Nocturnal Frontal Lobe Epilepsy-Report on Two Cases and Review of the First Taiwanese Series of 10 Cases. Acta Neurol Taiwan, 2017, 26(2): 55-63.
|
43. |
Bisulli F, Vignatelli L, Naldi I, et al. Diagnostic accuracy of a structured interview for nocturnal frontal lobe epilepsy (SINFLE): a proposal for developing diagnostic criteria. Sleep Med, 2012, 13(1): 81-87.
|
44. |
Scheffer IE, Bhatia KP, Lopes-Cendes I, et al. Autosomal dominant frontal epilepsy misdiagnosed as sleep disorder. Lancet, 1994, 343: 515-517.
|
45. |
Millichap JJ, Miceli F, De Maria M, et al. Infantile spasms and encephalopathy without preceding neonatal seizures caused by KCNQ2 R198Q, a gain-of-function variant. Epilepsia, 2017, 58(1): e10-e15.
|
46. |
Allen NM, Mannion M, Conroy J, et al. The variable phenotypes of KCNQ-related epilepsy. Epilepsia, 2014, 55(9): e99-e105.
|
47. |
Baulac S, Weckhuysen S. DEPDC5-Related Epilepsy. In: Adam MP, Ardinger HH, Pagon RA, et al., eds. GeneReviews®. Seattle (WA): University of Washington, Seattle; September 29, 2016.
|
48. |
Symonds JD, Zuberi SM, Stewart K, et al. Incidence and phenotypes of childhood-onset genetic epilepsies: a prospective population-based national cohort. Brain, 2019, 142(8): 2303-2318.
|
49. |
Numis AL, Angriman M, Sullivan JE, et al. KCNQ2 encephalopathy: delineation of the electroclinical phenotype and treatment response. Neurology, 2014, 82(4): 368-370.
|
50. |
Kurahashi H, Hirose S. Autosomal Dominant Nocturnal Frontal Lobe Epilepsy. In: Adam MP, Ardinger HH, Pagon RA, et al., eds. GeneReviews®. Seattle (WA): University of Washington, Seattle; May 16, 2002.
|
51. |
Scheffer IE. Autosomal dominant nocturnal frontal lobe epilepsy. Epilepsia, 2000, 41(8): 1059-1060.
|
52. |
Oldani A, Zucconi M, Asselta R, et al. Autosomal dominant nocturnal frontal lobe epilepsy. A video‐polysomnographic and genetic appraisal of 40 patients and delineation of the epileptic syndrome. Brain, 1998, 121(pt2): 205-223.
|